Simone Chevalier
Affiliations: | Université de Montréal, Montréal, Canada |
Area:
BiochemistryWebsite:
https://www.certara.com/staffmember/martine-allard/Google:
"Simone Chevalier"Bio:
DOI: 10.1016/0014-2964(75)90101-2
Mean distance: (not calculated yet)
Parents
Sign in to add mentorWalter G. Verly | grad student | 1973 | Université de Montréal | |
(À la recherche de la chalone endométriale) |
Children
Sign in to add traineePierre Allard | grad student | 2000 | Université de Montréal |
Isabelle Defoy | grad student | 2002 | Université de Montréal |
Lucie Hamel | grad student | 2004 | Université de Montréal |
Amina Zoubeidi | grad student | 2004 | Université de Montréal |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Derderian S, Benidir T, Scarlata E, et al. (2023) Cell-by-cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression. The Journal of Pathology. Clinical Research |
Ebrahimizadeh W, Guérard KP, Rouzbeh S, et al. (2023) A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients. British Journal of Cancer |
Dahmani C, Caron P, Simonyan D, et al. (2022) Preoperative Circulating 11-Oxygenated Androgens Are Associated With Metastasis-free Survival in Localized Prostate Cancer. The Journal of Urology. 101097JU000000000000 |
Rouleau M, Nguyen Van Long F, Turcotte V, et al. (2022) Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer. British Journal of Cancer |
Lacombe L, Hovington H, Brisson H, et al. (2022) UGT2B28 accelerates prostate cancer progression through stabilization of the endocytic adaptor protein HIP1 regulating AR and EGFR pathways. Cancer Letters. 215994 |
Derderian S, Vesval Q, Wissing MD, et al. (2022) Liquid biopsy-based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer. Clinical and Translational Science |
Bramhecha YM, Guérard KP, Audet-Walsh É, et al. (2022) Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients. Oncogene |
Emond JP, Lacombe L, Caron P, et al. (2021) Urinary oestrogen steroidome as an indicator of the risk of localised prostate cancer progression. British Journal of Cancer |
Ebrahimizadeh W, Guérard KP, Rouzbeh S, et al. (2020) Design and development of a fully synthetic MLPA-based probe mix for detection of copy number alterations in prostate cancer formalin-fixed, paraffin-embedded tissue samples. The Journal of Molecular Diagnostics : Jmd |
Patel PG, Wessel T, Kawashima A, et al. (2019) A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer. The Prostate |